A better baseline starts with you. Explore 1-, 3- & 6-month plans
Home/All products/Drive
DRIVE (PT-141)Vitality protocol01 / 08
Your next chapter starts here
Vitality · PT-141

Drive

$499 upfront$166.33 per month equivalent3 month plan

Sexual wellbeing deserves a thoughtful conversation. Explore PT-141, the evidence behind bremelanotide, and the questions to discuss with a licensed clinician.

Individual review Simple plan choices

Compare your plans

1, 3 or 6 months

$499 upfront for 3 months. Monthly figure is an equivalent, not monthly billing.

Your secure intake opens in a new tab. Choose your final plan there.

Start your intake

Prescription required. Subject to clinician approval.

What’s included?

A private medical assessment should clarify the concern and available options. If medication is proposed, the offer should state its exact identity, quantity, instructions and follow-up arrangements.

Check the total cost, included supplies, delivery and cancellation terms before accepting. Comparing a plan does not guarantee a prescription or a particular number of administrations.

How does enrollment work?

Start the secure intake in a new tab, then choose your final plan within the care service. Comparing durations here does not lock your choice or authorize payment. The care service handles assessment, prescribing decisions and payment terms.

Important information

Treatment is not appropriate for everyone. Review the safety information below and discuss risks, alternatives and your medical history with your provider.

THE PROTOCOL, EXPLAINED · PT-141

Drive.
Make space for connection.

PT-141Sexual wellbeingIndividual suitability

Drive opens a conversation about sexual desire and bremelanotide, also known as PT-141. Low desire can be influenced by health, medicines, relationships and life circumstances, so an individual assessment matters more than a performance promise.

FDA-approved Vyleesi has a specific indication for acquired, generalized hypoactive sexual desire disorder in premenopausal women. That approval should not be read as approval of every PT-141 preparation or every use.

Explore the science and suitability below. Goals are not guarantees of treatment benefit.

Drive · PT-141
Everyday movement and time outdoors
START WITH YOUR HEALTH

Start with you.
Your goals. Your health.

Your clinician will consider the pattern of low desire, medicines, health conditions and other possible causes. An approved indication for one patient group does not establish eligibility for men, postmenopausal women or other uses.

Disclose blood-pressure problems, heart disease, pregnancy plans and all medicines. The approved product must not be used with uncontrolled hypertension or known cardiovascular disease.

THE THINKING BEHIND IT

Understand the science.
Make an informed choice.

Bremelanotide is a melanocortin receptor agonist. Its exact mechanism for improving desire in the approved indication is not fully understood. It is not a testosterone replacement or a general-purpose sexual-performance medicine.

Evidence and instructions for the approved autoinjector apply to that product. A compounded preparation is not automatically equivalent; your clinician should identify the formulation and explain whether a proposed use is outside the approved indication.

Desire, in context

Health, medications and circumstances all belong in the conversation.

A specific indication

The branded approval is narrower than general libido marketing.

Private, personal review

Suitability and expectations are individual clinical decisions.

THE EVERYDAY PICTURE

A clearer picture
of your care.

Start by describing what has changed, whether it causes distress and what you want help with. The goal is an informed, pressure-free care decision, not a guarantee of desire or a particular sexual experience.

If treatment is appropriate, agree on how benefit and adverse effects will be reviewed. The plan duration displayed here is separate from any directions about when a medication may be used.

DRIVE (PT-141)
PERSONAL FROM THE START

What comes
with your plan.

A private medical assessment should clarify the concern and available options. If medication is proposed, the offer should state its exact identity, quantity, instructions and follow-up arrangements.

Check the total cost, included supplies, delivery and cancellation terms before accepting. Comparing a plan does not guarantee a prescription or a particular number of administrations.

Delivery, storage & your supply

The pharmacy confirms the prescribed product and fulfillment after approval. The final label, rather than a website image, establishes the formulation and administration instructions.

Review storage and any device instructions before first use. Ask the pharmacy or clinician if anything is unclear; do not translate instructions from a branded autoinjector into measurements for another preparation.

PRESCRIPTION CARE. PERSONAL BY DESIGN.

A considered route to care.

Your health history comes first. Treatment depends on an independent clinical decision, with instructions for the medication actually prescribed.

01

A proper intake

Share your health history, current medicines and goals through a secure medical questionnaire.

02

Independent review

A licensed clinician reviews suitability, risks and alternatives. A prescription is never automatic.

03

Clear pharmacy guidance

If prescribed, follow the dispensing pharmacy’s label, handling instructions and directions for use.

Compounded medicines are not FDA-approved. A prescription does not mean a treatment is right for everyone.

MAKE AN INFORMED CHOICE

Know what
to consider.

Bremelanotide can raise blood pressure temporarily and cause nausea, flushing, headache, vomiting or injection-site reactions. Skin darkening can occur. Discuss pregnancy and medicines, including oral naltrexone, with your clinician.

Read the full medication information for the exact product. Compounded PT-141 is not FDA-approved, and claims of equivalent performance or safety should not be assumed.

Sources & further reading
Drive · FAQs

A few things
you might be wondering.

Is Drive a treatment for erectile dysfunction?

The approved bremelanotide product is not indicated for erectile dysfunction or general sexual-performance enhancement. Discuss the actual concern with a clinician.

Is this Vyleesi?

Do not assume so. Check the exact medicine in the final care offer; compounded PT-141 is not the approved branded autoinjector.

Can men use the approved product for its labeled indication?

Its labeled HSDD indication is for premenopausal women, not men. Any other proposed use requires a clear clinical explanation.

Does a longer plan mean more frequent use?

No. Frequency and any limits come from the prescription and medication information, not the plan duration.

Will it work the first time?

A particular response cannot be guaranteed. Review realistic expectations and how benefit will be assessed.

Can I choose my plan at the end of intake?

The product page does not bind you to a plan. Make your final choice inside the care service’s intake before accepting its payment terms.

Drive

Your next step, at your pace.

Begin with your health history and goals. Choose your final plan inside the secure intake, with the details in front of you.

Start your intakePrescription required. Subject to clinician approval.

A little more Basis.

Explore all products
Drive3 -month plan
$166.33 / month$499 upfront
Start intake

Intake is not connected yet

You are viewing the draft site. No payment or medical information is collected here.

This product’s general intake link will be added here. Your final plan will be selected inside the care service’s intake, rather than fixed by the comparison above.